Panagora Asset Management Inc Allogene Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.78 - $12.28 $426,923 - $773,247	-62,968 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$7.65 - $15.29 $551,725 - $1.1 Million	-72,121 Reduced 53.39%	62,968 $574,000
Q4 2021 Feb 10, 2022	BUY	$13.13 - $24.52 $1.38 Million - $2.57 Million	104,825 Added 346.37%	135,089 $2.02 Million
Q2 2021 Aug 11, 2021	BUY	$23.49 - $35.8 $710,901 - $1.08 Million	30,264 New	30,264 $789,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.